Ocugen to Host Clinical Showcase in New York City on Wednesday, February 21, 2024
February 14, 2024 07:30 ET
|
Ocugen
Highlighting updates on OCU400 Phase 3 clinical trial starting early 2024 Featuring thought leaders in gene therapy and OCU400 Phase 1/2 clinical trial patient MALVERN, Pa., Feb. 14, 2024 ...
Intraocular Lens Market to Soar to USD 8,835 Million by 2033; Driven by Technological Advancements and Aging Population
February 12, 2024 06:21 ET
|
Market.Us
New York, Feb. 12, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the Intraocular Lens Market value is projected to exceed USD 8,835 Million by 2033, with a projected CAGR of 6.3% from 2024 to...
EyeMD EMR Healthcare Systems Inc. Receives the 2024 Best in KLAS Award for Ophthalmology EMR
February 07, 2024 15:09 ET
|
EyeMD EMR Healthcare Systems, Inc.
EyeMD EMR, a leading provider of clinical software solutions designed specifically for eye care, announced its receipt of the Best in KLAS Award.
Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering
February 07, 2024 08:00 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (“Clearside” or the “Company”) (NASDAQ: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to...
Global Ophthalmology Market Poised for Robust Growth: Comprehensive Research Forecast 2023-2030 Highlights Disease, Product, and End-User Segments
February 07, 2024 04:30 ET
|
Research and Markets
Dublin, Feb. 07, 2024 (GLOBE NEWSWIRE) -- The "Global Ophthalmology Market by Diseases (Age-Related Macular Degeneration, Cataract, Glaucoma), Product Type (Drugs, Equipment, Prescription Glasses...
ONL Therapeutics to Present at 2024 BIO CEO & Investor Conference
February 06, 2024 07:00 ET
|
ONL Therapeutics
ANN ARBOR, Mich., Feb. 06, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
New long-term data for Roche’s Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO)
February 01, 2024 01:03 ET
|
F. Hoffmann-La Roche Ltd
Vabysmo sustained robust drying of retinal fluid, often associated with distorted or blurry vision Up to 60% of people receiving Vabysmo were able to extend treatment intervals to three or four months...
Global Macular Degeneration Treatment Market Forecast to 2031: Breakthrough in Durable Anti-VEGF Drugs Redefines Patient Care with Less Frequent Dosing
January 26, 2024 06:27 ET
|
Research and Markets
Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Macular Degeneration Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade,...
Retinal Biologics Global Market Report 2023: Innovations Key to Future Advances - Long-term Forecasts to 2028 and 2033
January 25, 2024 09:33 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Retinal Biologics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. Profound analytics indicate that the...
Vitrectomy Devices Market Forecast to Surge at Rapid Pace Due to Rising Retinal Disorders and Technological Innovations by 2028
January 25, 2024 05:19 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Vitrectomy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2028" report has been added to ResearchAndMarkets.com's offering. ...